The Effects of Lovaza® in Acute Myocardial Infarction
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study will explore the safety and effectiveness of adding Lovaza® to the therapeutic
program utilized internationally for the treatment of individuals with acute coronary
syndromes.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Rochester
Collaborators:
Albany College of Pharmacy and Health Sciences GlaxoSmithKline